|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4704 | |
| A61P 35/00 |
| (11) | Number of the document | 1267848 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01903785.2 |
| Date of filing the European patent application | 2001-02-20 | |
| (97) | Date of publication of the European application | 2003-01-02 |
| (45) | Date of publication and mention of the grant of the patent | 2007-10-17 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2001/001937 |
| Date | 2001-02-20 |
| (87) | Number | WO 2001/062234 |
| Date | 2001-08-30 |
| (30) | Number | Date | Country code |
| 184551 P | 2000-02-24 | US |
| (72) |
END, David, William, US
|
| (73) |
Janssen Pharmaceutica NV,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (54) | DOSING REGIMEN COMPRISING A FARNESYL PROTEIN TRANSFERASE INHIBITOR FOR THE TREATMENT OF CANCER |
| DOSING REGIMEN COMPRISING A FARNESYL PROTEIN TRANSFERASE INHIBITOR FOR THE TREATMENT OF CANCER |